California SB 1120 physician directed utilization review denial appeal documentation strategy

California SB 1120 Utilization Review Denial Appeals: The Physician-Directed Documentation Playbook for 2026

Merry AI · Thoughtfully curated clinical briefs.

Clinically reviewed by Dr. Marcus Vance, MD (Medical Informatics Advisor) · Coding review by Kaif R. (Clinical Informatics Specialist) · Sources: CY 2026 CMS PFS, NCCI Policy Manual.

To overturn an SB 1120 denial, document the patient's individualized clinical circumstances in the record, then demand that the plan show a licensed physician or qualified health care professional reviewed those specific facts. An algorithm's scorecard is not enough. California's Physicians Make Decisions Act (SB 1120) took effect January 1, 2025. It amended Health and Safety Code Section 1367.01 and Insurance Code Section 10123.135. Under these amendments, artificial intelligence, algorithms, and software tools cannot supplant health care provider decision-making in medical necessity determinations.

For practice administrators and CMOs, this changes how appeals are won. You are no longer only arguing clinical merit. You are also testing whether the plan's process complied with the statute. This playbook covers the statutory hooks, specialty documentation thresholds, appeal packet structure, and the labor economics of building individualized records at scale.

SB 1120 bars plans from denying care based solely on algorithmic output

The statute sets enforceable conditions on any AI or algorithmic tool used in utilization review or utilization management. These conditions apply to plans licensed by the Department of Managed Health Care (DMHC) and to disability insurers regulated by the California Department of Insurance (CDI). The tool must base its determination on the following:

• The enrollee's medical or dental history, as documented in the record.
• Individual clinical circumstances as presented by the requesting provider.
• Other relevant clinical information contained in the enrollee's medical record.

The statute also sets limits. A tool may not base a determination solely on a group dataset. It must not discriminate, and it must be applied fairly and equitably. It must be open to inspection and audit by DMHC or CDI, and it must be periodically reviewed and revised for performance and accuracy. Patient data cannot be used beyond its intended and stated purpose.

Most importantly, any denial, delay, or modification based on medical necessity must be made by a licensed physician, or by a licensed health care professional competent to evaluate the specific clinical issues. That reviewer must consider the requesting provider's recommendation and the enrollee's history and individual circumstances. For statute-by-statute tracking across jurisdictions, see the State AI Scribe Rules & Statutory Compliance Hub.

Callout: Your record is the evidence. No individualized facts means no individualized review.

Section 1367.01 timelines create procedural leverage before any clinical argument

Plans must meet fixed decision clocks. Standard prospective and concurrent decisions are due within five business days of receiving the information reasonably necessary to decide, and never later than 14 calendar days from the request. When the enrollee faces an imminent and serious threat to health, the plan must decide within 72 hours. Decisions must reach the requesting provider within 24 hours of being made, first by telephone, fax, or electronic means.

Written denial notices must include several elements:

• A clear, concise explanation of the reasons for the decision.
• A description of the criteria or guidelines used.
• The clinical reasons for the medical necessity determination.
• The name and telephone number of the health care professional responsible for the decision.

A missing reviewer name is a defect. So is a boilerplate rationale that never mentions the patient's own findings. Both are procedural defects worth citing in the grievance and in any DMHC complaint.

Grievances follow Section 1368.01 timelines. Plans must resolve standard grievances within 30 calendar days and urgent grievances within three days. Unresolved medical necessity denials then qualify for DMHC Independent Medical Review (IMR) under Section 1374.30 and following. In IMR, outside physician reviewers evaluate the case. A well-built record often decides the outcome there.

Winning appeals pair patient-specific clinical indicators with explicit MDM documentation

Reviewing physicians respond to specificity. The table below maps two high-denial scenarios: chronic systolic heart failure (I50.22 (ICD-10-CM)) and right knee primary osteoarthritis (M17.11 (ICD-10-CM)). For each, it lists the clinical indicators, Medical Decision Making (MDM) level, and audit defenses that answer a denial.

Cardiology practices face concentrated exposure. Denials for advanced imaging, ICDs, and specialty pharmacy are common there. For specialty-specific grievance templates, see the California SB 1120 Utilization Review Defense brief.

An SB 1120 appeal packet should contain six evidentiary components

Structure every appeal the same way. Consistency lets your team build packets quickly, and it makes procedural defects easy to spot. Use these components in this order.

1. The denial notice, annotated for defects. Flag a missing reviewer name, a missed timeline, absent clinical reasons, or a criteria citation with no patient-specific application.
2. A treating physician letter of medical necessity. Keep it to one page. Restate the diagnosis, the specific objective findings, every failed therapy with dates, and the clinical risk of delay.
3. Source documentation excerpts. Include imaging reports, lab trends, medication histories with doses, and therapy logs. Highlight only the decisive findings.
4. A guideline crosswalk. Map each element of the relevant professional society guideline (ACC/AHA/HFSA heart failure guidelines, AAOS knee OA guidelines) to the record.
5. A peer-to-peer log. Record the date, time, reviewer name, reviewer specialty, and a summary of the discussion. Note whether the reviewer had reviewed the chart.
6. An explicit statutory request. Ask the plan to confirm, in writing, that a licensed physician or competent health care professional reviewed the individual clinical circumstances. Ask also whether an automated tool contributed to the determination.

Callout: Request reviewer specialty in writing. Competency mismatches are a documented grievance basis.

Peer-to-peer calls succeed when the reviewer must engage with documented facts

Prepare a 90-second clinical summary. Cover the diagnosis, the objective severity markers, the failed therapies, and the consequence of denial. Then ask the reviewer directly which documented finding fails the plan's criteria.

If the reviewer cannot name one, note that in the peer-to-peer log. It suggests the reviewer did not consider individual circumstances, which is the core standard SB 1120 enforces.

Ask the reviewer's board specialty. The statute requires competence to evaluate the specific clinical issues. A non-cardiologist denying a primary prevention ICD may not meet that standard, so document the mismatch.

Medicare Advantage denials fall under CMS-4201-F rather than SB 1120

Federal preemption limits SB 1120's reach. Most Medicare Advantage plans are outside it. However, CMS-4201-F, effective for coverage beginning January 1, 2024, requires MA organizations to base medical necessity decisions on the individual patient's circumstances. CMS guidance further states that algorithms and AI tools alone may not be the basis for denial.

The same documentation strategy works for MA appeals. Build an individualized record, request the reviewer's identity and specialty, and challenge any denial driven by group data. Cite the federal rule instead of California statute.

AI-drafted documentation supports appeals only after clinician review and attestation

Ambient AI scribes can capture detail that busy clinicians often leave out: medication trials, PT session counts, functional limits, and the patient's own account of decline. Those details are the individualized circumstances that win SB 1120 appeals.

The treating clinician must still own the note. They must review, edit, and attest to it before it enters the record or an appeal packet. A plan may challenge an unattested AI draft as unreliable.

Patient-facing outputs carry separate obligations. AB 3030 requires a disclaimer and human-contact instructions on generative AI patient communications containing clinical information. The exception is communications that a licensed provider has read and reviewed. See California AB 3030 Generative AI Disclosure Requirements for implementation details.

Individualized documentation costs 1.3% of one medical assistant's loaded salary

Manual appeal prep consumes staff hours. A fully loaded medical assistant in California costs roughly $48,000 per year, and much of that time goes to chart abstraction, prior authorization follow-up, and appeal assembly.

Merry AI Pro costs $648 per year ($54 per month, billed annually). That equals 1.3% of the $48,000 MA labor denominator. It produces structured, attestation-ready notes that already contain the indicators reviewers look for.

The same longitudinal documentation also captures revenue. CPT G2211, the visit complexity add-on for longitudinal care of a serious or complex condition, is often missed. Practices that capture it consistently on qualifying E/M visits recover $15,600 or more in annual revenue per clinician.

Under CY 2026 CMS PFS policy, G2211 remains billable with modifier 25 only when the same-day service is an annual wellness visit, a vaccine administration, or a Part B preventive service. Document the ongoing relationship explicitly at every qualifying visit.

Callout: One record serves two purposes. It wins appeals and supports G2211 capture.

CMOs should audit denial patterns quarterly against SB 1120 procedural requirements

Track every medical necessity denial by payer, service line, reviewer specialty, decision timeliness, and whether a reviewer name appeared on the notice. Patterns of missing names or specialty mismatches support a DMHC or CDI complaint, beyond individual appeals.

Report overturn rates to clinical leadership. When a payer's denials are repeatedly overturned on peer-to-peer or IMR, that is evidence its tools are not individualizing review. Regulators can audit those tools under the statute.

Frequently asked questions about SB 1120 utilization review denial appeals

Does SB 1120 apply to Medicare Advantage plans?

SB 1120 governs DMHC-licensed health plans and CDI-regulated disability insurers, including Medi-Cal managed care plans under Knox-Keene licensure. Medicare Advantage is largely federally preempted, but CMS-4201-F separately requires MA organizations to base medical necessity decisions on individual patient circumstances rather than algorithms alone.

Can a practice request the identity of the reviewing physician?

Yes. California Health and Safety Code Section 1367.01 requires written denial notices to include the name and telephone number of the licensed health care professional responsible for the decision. Practices should log this information and request a peer-to-peer conversation with that specific reviewer before filing a grievance.

What deadlines apply to plan decisions and appeals?

Standard prospective decisions must be made within five business days of receiving reasonably necessary information, capped at 14 calendar days, and urgent requests within 72 hours. Plan grievances resolve within 30 calendar days, or three days when urgent. Unresolved denials then qualify for DMHC Independent Medical Review.

Does an AI scribe note satisfy SB 1120 documentation needs?

An AI-drafted note supports SB 1120 appeals only after the treating clinician reviews, edits, and attests to it. The attested note should capture patient-specific findings, failed therapies, and risk factors, giving the plan's reviewing physician individualized clinical circumstances that population-based algorithms cannot supply.

How does G2211 relate to utilization review defense?

G2211 documents the longitudinal relationship that anchors a chronic condition's medical necessity narrative. Capturing it consistently recovers roughly $15,600 or more annually for a typical primary care or cardiology panel, and the same longitudinal documentation strengthens appeals by proving continuous, physician-directed management over time.